Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III equivalence trial of human fibrin sealant for hemostasis of liver surgery wound surfaces
CTR20250837Phase 3Active
- Sponsor
- Weiguang Biological
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil in Not applicable, Bleeding, sponsored by Weiguang Biological. Started May 2025; status: active.
02
Drugs
tachosil
03
Conditions
Not applicableBleeding
Beyond the preview
Go deeper on CTR20250837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250837.